Jakafi Tablets 10mg
Couldn't load pickup availability
You can promote by sharing on social networks on the links.
Product Description
Jakafi Tablets 10mg contains Ruxolitinib, a Janus kinase (JAK) inhibitor used to treat certain blood disorders, including myelofibrosis, polycythemia vera, and graft-versus-host disease (GVHD). It works by blocking abnormal JAK signaling pathways that contribute to disease progression.
Product Overview
Product Name: Jakafi Tablets 10mg
Generic Name: Ruxolitinib
Strength: 10mg
Form: Tablets
Pack Size: As per manufacturer packaging
Used For: Treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease
Prescription Required: Yes
Ingredients & How They Work
Each tablet contains Ruxolitinib 10mg, which inhibits Janus kinase (JAK1 and JAK2) enzymes to reduce abnormal blood cell production and inflammation.
Key Benefits
- Treats myelofibrosis
- Helps manage polycythemia vera
- Used for graft-versus-host disease (GVHD)
- Reduces spleen enlargement
- Helps relieve disease-related symptoms
How to Use
Take exactly as prescribed by your healthcare provider. Swallow the tablet whole with water, with or without food.
Side Effects & Precautions
Possible Side Effects
- Anemia
- Low platelet count
- Headache
- Dizziness
- Increased risk of infections
Precautions
- Regular blood count monitoring is required.
- Inform your doctor if you develop fever or signs of infection.
- Do not adjust the dosage without medical advice.
- Use only under specialist supervision.
Storage Instructions
Store below 30°C in a cool, dry place away from moisture and direct sunlight.
